Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 401–500 of 1,002
Gazzaruso, C., Coppola, A., Montalcini, T., Baffero, E., Garzaniti, A., Pelissero, G., Collaviti, S., Grugnetti, A., Gallotti, P., Pujia, A., et al. (2011) · Endocrine · doi:10.1007/s12020-011-9544-4 · Cited by 51
Simplified Diagnosis of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Using Ewing's Battery
Pafili, K., Trypsianis, G. A., Papazoglou, D., Maltezos, E. S., & Παπάνας, Ν. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.213 · Cited by 51
“The tests are widely used as they provide good sensitivity, specificity, and reproducibility, and they are wellstandardized and easily performed [8, 11, 12].”
BackgroundPrabodha, L. B. L., Sirisena, N. D., & Dissanayake, V. H. W. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8641942 · Cited by 57
“According to the Toronto Consensus Panel on Diabetic Neuropathy, DPN is defined as a symmetrical, lengthdependent sensorimotor polyneuropathy that develops on a background of longstanding hyperglycemia, associated derangements, and cardiovascular risk factors [16].”
BackgroundSekiguchi, K., Kohara, N., Baba, M., Komori, T., Naito, Y., Imai, T., Satoh, J., Yamaguchi, Y., Hamatani, T., & the Ranirestat Group (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12890 · Cited by 51
Early Electrophysiological Abnormalities and Clinical Neuropathy
Hyllienmark, L., Alstrand, N., Jönsson, B., Ludvigsson, J., Cooray, G., & Wahlberg-Topp, J. (2013) · Diabetes Care · doi:10.2337/dc12-2226 · Cited by 55
Ng, Y. T., Phang, S. C. W., Tan, G. C. J., Ng, E. Y., Botross, N. P., Palanisamy, U. D., Ahmad, B., & Kadir, K. A. (2020) · Nutrients · doi:10.3390/nu12051522 · Cited by 53
“In addition, NCS is recommended to be used in DPN-related controlled clinical trials and epidemiological surveys [1,14].”
BackgroundMethodResultInfluentialCardoso, C. R. L., Moran, C. B. M., Marinho, F. D. S., Ferreira, M. T., & Salles, G. F. (2015) · Diabetologia · doi:10.1007/s00125-015-3658-9 · Cited by 52
“Although the cornerstone role of optimal glycaemic control in preventing the development/progression of DPN in patients with type 1 diabetes is undisputed [1, 7, 8, 27], its importance in type 2 diabetes is more debatable.”
BackgroundMethodInfluentialRaafat, K. M., Aboul-Ela, M., & El-Lakany, A. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0372-y · Cited by 50
“Impairment of peripheral nerve conduction is an important parameter for diabetic patients having peripheral neuropathy (Said 2007; Tesfaye et al. 2010).”
BackgroundSmall Fiber Neuropathy: Is Skin Biopsy the Holy Grail?
Lauria, G., & Lombardi, R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0280-9 · Cited by 53
Self-citationSilva, M., Amorim, D., Almeida, A., Tavares, I., Pinto‐Ribeiro, F., & Morgado, C. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.04.008 · Cited by 56
Hsu, P.-C., Liao, P.-Y., Chang, H., Chiang, J. Y., Huang, Y., & Lo, L.-C. (2016) · Medicine · doi:10.1097/md.0000000000005714 · Cited by 51
“The trial protocol was approved by the Institutional Review Board of Changhua Christian Hospital, Changhua, Taiwan (institutional review board reference number: 111106).”
MethodThe impact of type 1 diabetes and diabetic polyneuropathy on muscle strength and fatigability
Orlando, G., Balducci, S., Bazzucchi, I., Pugliese, G., & Sacchetti, M. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0979-9 · Cited by 50
Brown, J. J., Pribesh, S. L., Baskette, K. G., Vinik, A. I., & Colberg, S. R. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1467213 · Cited by 60
Self-citationSantos, T. R. M., de Melo, J. V., Leite, N. C., Salles, G. F., & Cardoso, C. R. L. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.010 · Cited by 51
Eleftheriadou, I., Tentolouris, A., Grigoropoulou, P., Tsilingiris, D., Anastasiou, I. A., Kokkinos, A. D., Perrea, D. N., Katsilambros, N. L., & Tentolouris, N. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.008 · Cited by 50
Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study
van der Velde, J. H. P. M., Koster, A., Strotmeyer, E. S., Mess, W. H., Hilkman, D. M. W., Reulen, J. P. H., Stehouwer, C. D. A., Henry, R. M. A., Schram, M. T., Kallen, C., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05194-5 · Cited by 51
The impact of glycemic variability on diabetic peripheral neuropathy
Jin, H. Y., Lee, K. A., & Park, T. S. (2016) · Endocrine · doi:10.1007/s12020-016-1005-7 · Cited by 49
Raafat, K. M., & El-Lakany, A. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0780-7 · Cited by 51
“Declining of peripheral nerve conduction is an important indicator for diabetic patients having peripheral neuropathy [36–38].”
BackgroundKurajoh, M., Koyama, H., Kadoya, M., Naka, M., Miyoshi, A., Kanzaki, A., Kakutani‐Hatayama, M., Okazaki, H., Shoji, T., Moriwaki, Y., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0280-6 · Cited by 51
Perioperative management of adult diabetic patients. Intraoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.018 · Cited by 55
Self-citationA gain-of-function sodium channel β 2-subunit mutation in painful diabetic neuropathy
Alsaloum, M., Estación, M., Almomani, R., Gerrits, M. M., Bönhof, G. J., Ziegler, D., Malik, R. A., Ferdousi, M., Lauria, G., Merkies, I. S. J., et al. (2019) · Molecular Pain · doi:10.1177/1744806919849802 · Cited by 54
Self-citationHimeno, T., Kamiya, H., & Nakamura, J. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13173 · Cited by 54
Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes
Palavicini, J. P., Chen, J., Wang, C., Wang, J., Qin, C., Baeuerle, E., Wang, X., Woo, J. A., Kang, D. E., Musi, N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137286 · Cited by 55
“Introduction Diabetic peripheral neuropathy, the most common complication of diabetes mellitus, is a neurodegenerative disease of the PNS that represents a significant source of morbidity and mortality associated with diabetes (1, 2).”
BackgroundBen, Y., Hao, J., Zhang, Z., Xiong, Y., Zhang, C., Chang, Y., Yang, F., Li, H., Zhang, T., Wang, X., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s301068 · Cited by 49
“nerve integrity and a means to monitor disease onset and progression.(37) In rodent models of diabetic neuropathy, NCV measurements are commonly used”
BackgroundTranslation and linguistic validation of the Composite Autonomic Symptom Score COMPASS 31
Pierangeli, G., Turrini, A., Giannini, G., Sorbo, F. D., Buonaura, G. C., Guaraldi, P., Reggiani, M. L. B., & Cortelli, P. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2278-y · Cited by 59
Herder, C., Bongaerts, B. W. C., Rathmann, W., Heier, M., Kowall, B., Köenig, W., Thorand, B., Roden, M., Meisinger, C., & Ziegler, D. (2014) · Diabetes Care · doi:10.2337/dc14-1403 · Cited by 55
Tesfaye, S. H. (2014) · Medicine · doi:10.1016/j.mpmed.2014.10.013 · Cited by 49
Self-citationA trial of proficiency of nerve conduction: Greater standardization still needed
Dyck, P. J. B., Albers, J. W., Wolfe, J., Bolton, C. F., Walsh, N. S., Klein, C. J., Zafft, A. J., Russell, J. W., Thomas, K., Davies, J. L., et al. (2012) · Muscle & Nerve · doi:10.1002/mus.23765 · Cited by 52
Self-citationPerineural Platelet-Rich Plasma for Diabetic Neuropathic Pain, Could It Make a Difference?
Hassanien, M. M., Elawamy, A. M., Kamel, E. Z., Khalifa, W. A. M., Abolfadl, G. M., Roushdy, A. S., Zohne, R. A. E., & Makarem, Y. S. (2019) · Pain Medicine · doi:10.1093/pm/pnz140 · Cited by 48
Singh, R., Arbaz, M., Rai, N. K., & Joshi, R. P. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s214085 · Cited by 52
Genetic aspects of sodium channelopathy in small fiber neuropathy
Hoeijmakers, J. G. J., Merkies, I. S. J., Gerrits, M. M., Waxman, S. G., & Faber, C. G. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01937.x · Cited by 49
“In addition to the clinical picture, the diagnosis of SFN can be confirmed by demonstration of a reduced intraepidermal nerve fiber density in skin biopsy and/or abnormal thermal thresholds in quantitative sensory testing (7, 8).”
BackgroundHata, M., Omi, M., Kobayashi, Y., Nakamura, N., Tosaki, T., Miyabe, M., Kojima, N., Kubo, K., Ozawa, S., Maeda, H., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0156-4 · Cited by 48
“Its various symptoms not only reduce the quality of life, but the existence of DPN affects mortality [10].”
BackgroundEvaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy
Pourhamidi, K., Dahlin, L. B., Englund, E. M., & Rolandsson, O. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.04.004 · Cited by 49
“7 Definition of DSPN The definition presented by the Toronto Diabetic Neuropathy Expert Group, states that an abnormal nerve conduction study and symptom(s) or sign(s) of neuropathy confirms clinical DSPN [5, 9] In order to assess DSPN objectively, we did not include subjective symptoms in the definition of DSPN.”
BackgroundInfluentialMicronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
Schifilliti, C., Cucinotta, L., Fedele, V., Ingegnosi, C., Luca, S., & Leotta, C. (2014) · Pain Research and Treatment · doi:10.1155/2014/849623 · Cited by 48
“Clinical manifestations are characterized by painful symptoms, o)en associated with nocturnal exacerbations, described as deep, sharp, and stinging pain, and burning with hyperalgesia/allodynia, o)en accompanied by a progressive decrease in sensitivity [2, 3].”
BackgroundCha, S., Park, Y., Yun, J., Lee, S., Ahn, Y., Kim, S., & Ko, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.001 · Cited by 54
“The staging of CAN was defined as follows: a score of 0 was defined as normal autonomic function; a score of 1 was defined as early-stage CAN; and a score of at least 2 was defined as a definite diagnosis of CAN [7, 8].”
BackgroundMethodNovel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes
Sommese, L., Benincasa, G., Lanza, M., Sorriento, A., Schiano, C., Lucchese, R., Alfano, R., Nicoletti, G. F., & Claudio Napoli, A. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.012 · Cited by 50
Koetsier, E., Franken, G., Debets, J., Heijmans, L., van Kuijk, S. M. J., Linderoth, B., Joosten, E. A. J., & Maino, P. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13192 · Cited by 51
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management
Spallone, V., Lacerenza, M. R., Rossi, A., Sicuteri, R., & Marchettini, P. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318243075c · Cited by 59
Self-citationMallick‐Searle, T., & Adler, J. A. (2024) · Journal of Pain Research · doi:10.2147/jpr.s442595 · Cited by 57
“15 The pathophysiological processes involved in the development of painful DPN are complex and appear to involve sustained hyperglycemia, dyslipidemia, and altered insulin signaling.”
Yun, J., Kim, J., Song, K., Ahn, Y., Yoon, K., Yoo, K., Park, Y., & Ko, S. (2013) · Diabetes Care · doi:10.2337/dc13-1164 · Cited by 47
Mogensen, U. M., Jensen, T. J., Køber, L., Kelbæk, H., Mathiesen, A. S., Dixen, U., Rossing, P. R., Hilsted, J., & Kofoed, K. F. (2012) · Diabetes · doi:10.2337/db11-1235 · Cited by 48
Raafat, K. M., & Samy, W. M. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/180495 · Cited by 47
Orthostatic hypotension in diabetic patients—10-year follow-up study
Gašpar, Ľ., Kružliak, P., Komorníková, A., Celecová, Z., Krahulec, B., Baláž, D., Sabaka, P., Čaprnda, M., Kucera, M., Rodrigo, L., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.020 · Cited by 52
NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy
Ponirakis, G., Odriozola, M. N., Odriozola, S., Petropoulos, I. N., Azmi, S., Fadavi, H., Alam, U., Asghar, O., Marshall, A. G., Miro, A., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.12.023 · Cited by 47
Self-citationDehghani, C., Pritchard, N., Edwards, K. P., Russell, A. W., Malik, R. A., & Efron, N. (2016) · Cornea · doi:10.1097/ico.0000000000000760 · Cited by 47
Self-citationCefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dc16-1143 · Cited by 48
Kobayashi, S., Nagao, M., Asai, A., Fukuda, I., Oikawa, S., & Sugihara, H. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12772 · Cited by 50
Non‐length‐dependent small fiber neuropathy: Not a matter of stockings and gloves
Gemignani, F., Bellanova, M. F., Saccani, E., & Pavesi, G. (2021) · Muscle & Nerve · doi:10.1002/mus.27379 · Cited by 53
“symptoms and clinical signs of small fiber damage, and reduced IENFD at the ankle, and/or abnormal QST thermal thresholds at the foot.(3,8,9)”
BackgroundGylfadottir, S. S., Itani, M., Kristensen, A. G., Tankisi, H., Jensen, T. S., Sindrup, S. H., Bennett, D., Nyengaard, J. R., Finnerup, N. B., & Karlsson, P. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001111 · Cited by 49
Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
Kaku, M. C., Vinik, A. I., & Simpson, D. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0609-2 · Cited by 52
Self-citationMiranda‐Díaz, A. G., Román-Pintos, L. M., Rodríguez-Carrizález, A. D., Troyo‐Sanromán, R., Alatorre-Carranza, M. D. P., Cardona-Muñóz, E. G., & Hernandez-Ojeda, J. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s65500 · Cited by 46
“The reason for this approach lies in the existence of subclinical DPN and difficulties in quantifying neuropathic symptoms despite standardized questionnaires developed for this purpose.(22) Recently, an association between use of statins and peripheral neuropathy has been suggested; however, the evidence for this rel…”
BackgroundDiabetic Peripheral Neuropathy and the Management of Diabetic Peripheral Neuropathic Pain
Morales‐Vidal, S., Morgan, C., McCoyd, M., & Hornik, A. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.07.2576 · Cited by 51
Robinson, C. C., Balbinot, L. F., Silva, M. F., Achaval, M., & Zaro, M. A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700503 · Cited by 47
Using stratified medicine to understand, diagnose, and treat neuropathic pain
Themistocleous, A. C., Crombez, G., Baskozos, G., & Bennett, D. (2018) · Pain · doi:10.1097/j.pain.0000000000001301 · Cited by 49
“This suggests that a brain-based pain-facilitating mechanism contributes to chronic NeuP in DPN.”
BackgroundInfluentialWon, J. C., Kwon, H., Moon, S., Chun, S. W., Kim, C. H., Park, I. B., Kim, I. J., Lee, J., Cha, B. Y., & Park, T. S. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0099 · Cited by 50
Patel, K., Horak, H. A., & Tiryaki, E. (2020) · Muscle & Nerve · doi:10.1002/mus.27014 · Cited by 63
“Diabetic neuropathies are the most prevalent complication of diabetes, affecting about half of diabetic patients.(1) Diabetes can cause a variety of acute and chronic neuropathies, affecting the nerves, plexus, and/or roots.”
BackgroundAndersen, H. H., Olsen, R. V., Møller, H. G., Eskelund, P. W., Gazerani, P., & Arendt‐Nielsen, L. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00380.x · Cited by 55
“A recent case study of a NP patient with cold allodynia found a group of C-nociceptors to be abnormally cold and L-menthol responsive, indicating TRPM8 involvement in this particular case of SFNP related cold allodynia (Serra et al., 2009).”
BackgroundInfluentialAnnersten Gershater, M., Pilhammar, E., Apelqvist, J., & Alm-Roijer, C. (2011) · European Diabetes Nursing · doi:10.1002/edn.189 · Cited by 47
Nabi, B. N., Sedighinejad, A., Haghighi, M., Biazar, G., Hashemi, M., Haddadi, S., & Fathi, A. (2015) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.29280 · Cited by 47
“Hyperalgesia and allodynia are usually present upon examination (3).”
BackgroundHotaling, J. M., Sarma, A. V., Patel, D. P., Braffett, B. H., Cleary, P. A., Feldman, E. L., Herman, W. H., Martin, C. L., Jacobson, A. M., Wessells, H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0059 · Cited by 46
Pascal, M. M. V., Themistocleous, A. C., Baron, R., Binder, A., Bouhassira, D., Crombez, G., Finnerup, N. B., Gierthmühlen, J., Granovsky, Y., Groop, L., et al. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14576.2 · Cited by 45
“To diagnose peripheral neuropathy, we use the criteria outlined by Tesfaye, et al.(47) that classify neuropathy as possible, probable or confirmed:”
Andersen, S. T., Grosen, K., Tankişi, H., Charles, M., Andersen, N. T., Andersen, H., Petropoulos, I. N., Malik, R. A., Jensen, T. S., & Karlsson, P. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.016 · Cited by 46
Self-citationLai, Y., Huang, C., Chiu, W.-C., Liu, R., Tsai, N., Wang, H., Lin, W.-C., Cheng, B., Su, Y., Su, C.-M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00458 · Cited by 49
Gabriel, R., Boukichou-Abdelkader, N., Acosta, T., Gilis‐Januszewska, A., Gómez‐Huelgas, R., Makrilakis, K., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231196 · Cited by 52
Abdissa, D., Hamba, N., Kene, K., Bedane, D. A., Etana, G., Muleta, D., & Gerbi, A. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9562920 · Cited by 53
“The Toronto Consensus Panel defined DPN as a symmetrical, length-dependent sensorimotor polyneuropathy attributable to metabolic and microvessel alterations as a result of chronic hyperglycemia exposure [8].”
BackgroundOxaliplatin‐ and docetaxel‐induced polyneuropathy: clinical and neurophysiological characteristics
Bennedsgaard, K., Ventzel, L., Andersen, N. T., Themistocleous, A. C., Bennett, D., Jensen, T. S., Tankişi, H., & Finnerup, N. B. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12413 · Cited by 48
“The predefined case definition of polyneuropathy was the definition proposed by the Toronto Diabetic Neuropathy Expert Group of “possible”, “probable”, and “confirmed” polyneuropathy (Table S1).(19,39)”
BackgroundD’Onofrio, L., Kalteniece, A., Ferdousi, M., Azmi, S., Petropoulos, I. N., Ponirakis, G., Alam, U., Asghar, O., Marshall, A. G., Boulton, A. J. M., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.5 · Cited by 47
Self-citationWu, S., Han, Y., Hu, Q., Zhang, X., Cui, G., Li, Z., & Guan, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9823-4 · Cited by 45
“Diabetic peripheral neuropathy (DPN) is a symmetrical, length-dependent sensorimotor polyneuropathy associated with metabolic and microvessel alterations which innervates almost all systems, and even organs, via affecting pain fibers, motor neurons, and the autonomic nervous system [1].”
BackgroundExcitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain
Breitinger, U., & Breitinger, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00647-0 · Cited by 46
Association between depression and neuropathy in people with type 2 diabetes: a meta‐analysis
Bartoli, F., Carrà, G., Crocamo, C., Carretta, D., La Tegola, D., Tabacchi, T., Gamba, P., & Clerici, M. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4397 · Cited by 44
“Actually, neuropathies in patients with diabetes vary in terms of symptoms, patterns of neurologic involvement, course, pathologic alterations and underlying mechanisms (Tesfaye et al., 2010).”
BackgroundSudomotor Testing of Diabetes Polyneuropathy
Krieger, S.-M., Reimann, M., Haase, R., Henkel, E., Hanefeld, M., & Ziemssen, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00803 · Cited by 48
Tear film substance P: A potential biomarker for diabetic peripheral neuropathy
Tummanapalli, S. S., Willcox, M. D. P., Issar, T., Yan, A., Pisarcikova, J., Kwai, N. C. G., Poynten, A. M., Krishnan, A. V., & Markoulli, M. P. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.08.010 · Cited by 44
Yamagata, R., Nemoto, W., Nakagawasai, O., Takahashi, K., & Tan–No, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113825 · Cited by 44
Chen, D., Wang, M., Shang, X. C., Liu, X., Liu, X., Ge, T., Ren, Q., Ren, X., Song, X., Xu, H., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109040 · Cited by 51
NAFLD in type 1 diabetes: overrated or underappreciated?
Mertens, J., Gaal, L. F. V., Francque, S., & Block, C. E. M. D. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211055557 · Cited by 47
Obrosova, I. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.709 · Cited by 44
“The presence of diabetic autonomic neuropathy in this model is not surprising, considering that diabetic Akita mice develop severe hyperglycemia, which has been identified as one of the major causes of this devastating complication in both experimental and clinical studies (36).”
Liu, K., Song, Y., Yuan, Y., Li, Z., Wang, X., Zhang, W., Li, Y., Mi, X., Han, D., Rong, Y., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12070951 · Cited by 43
“We collected glycemic control factors, such as preoperative fasting blood glucose (FBG), HbA1c, SIH, GG, perioperative insulin administration, hypoglycemia [24], and duration and complications of type 2 diabetes mellitus (T2DM) (diabetic peripheral neuropathy [25], diabetic peripheral vascular disease [26]).”
Assessing Corneal Confocal Microscopy and Other Small Fiber Measures in Diabetic Polyneuropathy
Gylfadottir, S. S., Itani, M., Kristensen, A. G., Nyengaard, J. R., Sindrup, S. H., Jensen, T. S., Finnerup, N. B., & Karlsson, P. (2023) · Neurology · doi:10.1212/wnl.0000000000206902 · Cited by 44
Ziegler, D., Herder, C., & Παπάνας, Ν. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3693 · Cited by 52
“For example, if DSPN was defined as “possible” by the Toronto criteria, 28 in the study by Kurisu et al. (2019) the prevalence reached 17.4% in the NGT population, but if it was defined by more stringent criteria as “probable” or “confirmed” the prevalence dropped to 4.2% for these definitions…”
BackgroundInfluentialKim, E. S., Lee, S. W., Mo, E. Y., Moon, S. D., & Han, J. H. (2015) · Endocrine · doi:10.1007/s12020-015-0583-0 · Cited by 43
Li, J., Zhang, W., Wang, X., Yuan, T., Liu, P., Wang, T., Shen, L., Huang, Y., Li, N., You, H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190699 · Cited by 44
Kopf, S., Groener, J. B., Κender, Ζ., Fleming, T. H., Bischoff, S., Jende, J. M. E., Schumann, C., Ries, S. J., Bendszus, M., Schuh‐Hofer, S., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.020 · Cited by 43
D’Amato, C., Greco, C., Lombardo, G., Frattina, V., Campo, M., CEFALO, C. M. A., Izzo, V., Lauro, D., & Spallone, V. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12366 · Cited by 43
“Compass 31 75 (50-99) 56 (45-67) 20 (8-32) 94 (87-100) 1.”
Self-citationKarlsson, P., Provitera, V., Caporaso, G., Stancanelli, A., Saltalamacchia, A. M., Borreca, I., Manganelli, F., Santoro, L., Jensen, T. S., & Nolano, M. (2020) · Pain · doi:10.1097/j.pain.0000000000002054 · Cited by 46
Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept
Bent, B., Cho, P. J., Wittmann, A., Thacker, C., Muppidi, S., Snyder, M., Crowley, M. J., Feinglos, M., & Dunn, J. P. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002027 · Cited by 40
A Review on Antidiabetic Activity of Centaurea spp.: A New Approach for Developing Herbal Remedies
Fattaheian-Dehkordi, S., Hojjatifard, R., Saeedi, M., & Khanavi, M. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5587938 · Cited by 53
Chen, M., Zhu, Y., Wang, J., Wang, G., & Wu, Y. (2021) · Journal of Pain Research · doi:10.2147/jpr.s304595 · Cited by 44
Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction
Sun, P.-C., Chen, C.-S., Kuo, C., Lin, H.-D., Chan, R., Kao, M.-J., & Wei, S.-H. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.06.002 · Cited by 43
Wang, X., Huan, Y., Li, C., Cao, H., Sun, S., Lei, L., Liu, Q., Liu, S., Ji, W., Liu, H., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114221 · Cited by 42
Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?
Serhiyenko, V. A., & Serhiyenko, A. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.245 · Cited by 46
Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice
Wang, L., Chopp, M., Szalad, A., Liu, Z., Lü, M., Zhang, L., Zhang, J., Zhang, R. L., Morris, D., & Zhang, Z. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.002 · Cited by 44
Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes
Eranki, V., Santosh, R., Rajitha, K., Pillai, A., SOWMYA, P., Dupin, J., & Calvet, J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.003 · Cited by 42
“It has been suggested that sudomotor function should be included in the diagnosis of early peripheral autonomic neuropathy in diabetes [5].”
BackgroundChannelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?
Hoeijmakers, J. G. J., Faber, C. G., Merkies, I. S. J., & Waxman, S. G. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.003 · Cited by 44
Won, J. C., Kim, S. S., Ko, K. S., & Cha, B. Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.1.25 · Cited by 48
Körei, A. E., Istenes, I., Παπάνας, Ν., & Kempler, P. (2015) · Angiology · doi:10.1177/0003319715583595 · Cited by 43
“The main physiological function of small unmyelinated type C fibers is warm perception.(1,2) They also play a minor role in cold thermal perception.”
BackgroundInfluentialSelf-citationAssociation between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes
Ciccacci, C., Latini, A., Greco, C., Politi, C., D’Amato, C., Lauro, D., Novelli, G., Borgiani, P., & Spallone, V. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.011 · Cited by 45
Self-citationGalosi, E., Cesa, S. L., Stefano, G. D., Karlsson, P., Fasolino, A., Leone, C. M., Biasiotta, A., Cruccu, G., & Truini, A. (2018) · European Journal of Pain · doi:10.1002/ejp.1259 · Cited by 42
Itani, M., Gylfadottir, S. S., Krøigård, T., Kristensen, A. G., Christensen, D. H., Karlsson, P., Möller, S., Andersen, H., Tankişi, H., Nielsen, J. S., et al. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12424 · Cited by 46
“No DPN, possible DPN, probable DPN, and definite DPN were defined according to the Toronto Consensus Criteria.(17) Probable and definite DPN constituted the neuropathy group while no DPN constituted the control group.”
BackgroundMethodInfluentialEpidermal innervation morphometry by immunofluorescence and bright‐field microscopy
Nolano, M., Biasiotta, A., Lombardi, R., Provitera, V., Stancanelli, A., Caporaso, G., Santoro, L., Merkies, I. S. J., Truini, A., Porretta‐Serapiglia, C., et al. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12146 · Cited by 42
“We enrolled 55 healthy subjects and 63 patients with possible or probable SFN (36 diabetic patients, 27 idiopathic) according to published criteria (Tesfaye et al., 2010).”
MethodSelf-citationQuantitation of Sudomotor Innervation in Skin Biopsies of Patients With Diabetic Neuropathy
Luo, K., Chao, C., Chen, Y., Huang, C., Yang, N. C., Kan, H., Wang, S.-H., Yang, W., & Hsieh, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318230b0f4 · Cited by 42
“Previous studies mainly depended on functional studies to assess autonomic neuropathy (4, 38).”
Background
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.